I A Global Asset Management Inc. Alnylam Pharmaceuticals, Inc. Transaction History

I A Global Asset Management Inc.

  • $5.69 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024
BUY
$143.31 - $247.0 $337,781 - $582,179
2,357 Added 30.35%
10,122 $2.46 Million
Q1 2024

May 15, 2024
BUY
$146.51 - $198.2 $250,532 - $338,922
1,710 Added 28.24%
7,765 $1.16 Million
Q4 2023

Feb 14, 2024
BUY
$151.41 - $196.57 $284,802 - $369,748
1,881 Added 45.06%
6,055 $1.16 Million
Q3 2023

Nov 15, 2023
BUY
$170.77 - $211.65 $712,793 - $883,427
4,174 New
4,174 $739,000

Others Institutions Holding ALNY

# of Institutions
643
Shares Held
109M
Call Options Held
1.28M
Put Options Held
1.21M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $29.6B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track I A Global Asset Management Inc. Portfolio

Follow I A Global Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of I A Global Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on I A Global Asset Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email